Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -105.71% is 214% below its 5-year average of -33.70%, near the high end of its 5-year range (-707.42%–0.00%).
130.20% below its 12-month average of -45.92%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2025 (2025-12-31): 0.00%.
NET PROFIT MARGIN
-105.71%
NET PROFIT MARGIN AVG TTM
-45.92%
NET PROFIT MARGIN AVG 3Y
-155.03%
NET PROFIT MARGIN AVG 5Y
-33.70%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-130.20%
CURRENT VS 3Y AVG
+31.81%
CURRENT VS 5Y AVG
-213.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Moolec Science S.A.
Market Cap
$3.57M
Net Profit Margin
-105.71%
TTM Avg
-45.92%
3Y Avg
-155.03%
5Y Avg
-33.70%
Market Cap
$3.49M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-523.72%
5Y Avg
-1138.73%
Market Cap
$3.51M
Net Profit Margin
-4139.38%
TTM Avg
-3617.24%
3Y Avg
-2890.13%
5Y Avg
-2863.43%
Market Cap
$3.23M
Net Profit Margin
-87.20%
TTM Avg
-5303.47%
3Y Avg
-2728.60%
5Y Avg
-1828.05%
Market Cap
$3.23M
Net Profit Margin
0.00%
TTM Avg
-9993.13%
3Y Avg
-11306.74%
5Y Avg
-8768.57%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.57M | -105.71% | -45.92% | -155.03% | -33.70% |
| Eocene Ltd. (EOCN)vs › | $3.49M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | 0.00% | 0.00% | -523.72% | -1138.73% |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | -4139.38% | -3617.24% | -2890.13% | -2863.43% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | -87.20% | -5303.47% | -2728.60% | -1828.05% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | 0.00% | -9993.13% | -11306.74% | -8768.57% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | -427.67% | -455.53% | -478.79% | -375.12% |
Operating Margin
-3.1%
Net Profit Margin
-105.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2024-12-31 | -91.84% |
| 2024-09-30 | -123.02% |
| 2024-06-30 | -166.47% |
| 2024-03-31 | -66.46% |
| 2023-12-31 | -707.42% |
| 2023-09-30 | -91.43% |
| 2023-06-30 | -303.63% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |